Aging
Navigate
Submit an Article
Research Paper|Volume 16, Issue 1|pp. 389–401
The predictive value of sarcopenia and myosteatosis in trans-arterial (chemo)-embolization treated HCC patients
Back to articleFigure 5(5 of 7)
100%
Figure 5
Figure 5.(A) The relationship between PMI and OS in TAE or TACE treated HCC patients; (B) The relationship between myosteatosis and OS in TAE or TACE treated HCC patients.